SLC2A1 and movement disorder: The third patient, a 28-year-old woman with early-onset developmental delay, epilepsy, and movement disorders was treated with a ketogenic diet following the identification of a variant in <i>SLC2A1</i>, confirming a glucose transporter type 1 deficiency syndrome.